{"title":"广谱唑类药物治疗马拉塞氏菌血流感染的潜在作用","authors":"Sunish Shah , M. Hong Nguyen","doi":"10.1016/j.mmcr.2023.05.002","DOIUrl":null,"url":null,"abstract":"<div><p>Amphotericin B is the currently recommended therapy for <em>Malassezia</em> invasive infection (MII), but this drug requires intravenous administration and is associated with significant toxicity. The role of broad-spectrum azoles in managing MII is not clear. We describe two cases of MII due to <em>M. pachydermatis</em> and <em>M. furfur</em> that were successfully treated with posaconazole and reviewed the literature to assess the position of posaconazole in treating MII.</p></div>","PeriodicalId":51724,"journal":{"name":"Medical Mycology Case Reports","volume":"41 ","pages":"Pages 1-3"},"PeriodicalIF":1.6000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Potential role of broad-spectrum azoles as therapy for Malasezzia bloodstream infection\",\"authors\":\"Sunish Shah , M. Hong Nguyen\",\"doi\":\"10.1016/j.mmcr.2023.05.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Amphotericin B is the currently recommended therapy for <em>Malassezia</em> invasive infection (MII), but this drug requires intravenous administration and is associated with significant toxicity. The role of broad-spectrum azoles in managing MII is not clear. We describe two cases of MII due to <em>M. pachydermatis</em> and <em>M. furfur</em> that were successfully treated with posaconazole and reviewed the literature to assess the position of posaconazole in treating MII.</p></div>\",\"PeriodicalId\":51724,\"journal\":{\"name\":\"Medical Mycology Case Reports\",\"volume\":\"41 \",\"pages\":\"Pages 1-3\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical Mycology Case Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2211753923000209\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Mycology Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211753923000209","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
Potential role of broad-spectrum azoles as therapy for Malasezzia bloodstream infection
Amphotericin B is the currently recommended therapy for Malassezia invasive infection (MII), but this drug requires intravenous administration and is associated with significant toxicity. The role of broad-spectrum azoles in managing MII is not clear. We describe two cases of MII due to M. pachydermatis and M. furfur that were successfully treated with posaconazole and reviewed the literature to assess the position of posaconazole in treating MII.